Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis- 4-Year Outcomes from the Rapid-Psa Study
Abstract
Authors
D Gladman R Fleischmann K Harris L Peterson PJ Mease
D Gladman R Fleischmann K Harris L Peterson PJ Mease
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now